Michael McCollum, DPM
Foot Surgery · Montgomery, ALNPI 1720510753
Payments from drug & device makers
What this record shows
Kerecis Limited accounts for 74.9% of it on its own, with 8 other manufacturers making up the rest.
Across 29 payments — averaging $73.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$2K
- ANI Pharmaceuticals, Inc.$305
- Organogenesis Inc.$54
- Amgen$48
- Paratek Pharmaceuticals, Inc.$48
- Smith+Nephew$27
- plus $57 from 3 others
What the payments were for
- Travel & lodging$1,21857%
- Food & beverage$92743%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 9 | $1,606 |
| ANI Pharmaceuticals, Inc. | 10 | $305 |
| Organogenesis Inc. | 2 | $54 |
| Amgen | 2 | $48 |
| Paratek Pharmaceuticals, Inc. | 2 | $48 |
| Smith+Nephew | 1 | $27 |
| Mimedx Group, Inc. | 1 | $21 |
| Johnson & Johnson | 1 | $20 |
| Bioventus LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$5,329
- Kerecis GraftGuide$1,332
How this compares
$2,145 in reported general payments places this provider in the 70th percentile of 35 foot surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitro-BidNitroglycerin | 20 | $1,485 |
| Ammonium Lactate | 38 | $988 |
| Doxycycline Hyclate | 21 | $359 |
| Clotrimazole | 29 | $261 |
| Ciprofloxacin Hcl | 14 | $211 |
| Celecoxib | 17 | $197 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $113 |
| SsdSilver Sulfadiazine | 12 | $94 |
| Meloxicam | 20 | $69 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Montgomery
- Hadryan VaughnMontgomery$1K
- Theresa BrownMontgomery$493
- Brooke GorhamGadsden$211K
- Eric FillingerCullman$19K
- John VanoreGadsden$17K
- Jean PrattGadsden$8K
- Robert RussellBirmingham$7K
- Richard HarrisBirmingham$6K
- James BowmanSylacauga$4K
- Robson AraujoAlbertville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.